CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Biogen against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Liquid Pharmaceutical CompositionFRESENIUS KABI DEUTSCHLANDOct 5, 2022
Liquid Pharmaceutical CompositionARES TRADINGJul 22, 2020
Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTJun 19, 2019
Liquid Pharmaceutical CompositionARES TRADINGMar 26, 2019

Explore Biogen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1
Jan 24, 2024Optimized Factor Viii Gene1
Nov 22, 2023Methods Of Treating Or Preventing Spinal Muscular Atrophy5
Oct 18, 2023A Limiter For A Dispensing Device2
Apr 26, 2023Use Of Raman Spectroscopy To Monitor Culture Medium2
Dec 14, 2022Assay For Jc Virus Antibodies1
Nov 30, 2022Method Of Assessing Risk Of Pml2
Aug 24, 2022Compositions And Uses For Treating Multiple Sclerosis14
Aug 10, 2022Methods For Overcoming Glutamine Deprivation During Mammalian Cell Culture1

Top competitors of Biogen

Top competitors of Biogen based on patent oppositions.